"Very High Risk" Isn't Very Helpful

“Very High Risk” Isn’t Very Helpful

A more detailed look at how I think about risks for precommercial drug developer recommendations.

January 26, 2022

– Advisor: Maxx Chatsko

Industries: Biotechnology

Please log in or subscribe to 7investing Premium to access this advisor update.